66 related articles for article (PubMed ID: 2976323)
1. [Reverse hemagglutination (RHA) test for detection of ovarian cancer antigen in serum].
Liu WS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):308-9. PubMed ID: 2976323
[No Abstract] [Full Text] [Related]
2. [Human ovarian cancer antigen assayed by an active rosette formation test for immunodiagnosis].
Gong Y
Zhonghua Fu Chan Ke Za Zhi; 1983 Jul; 18(3):164-6. PubMed ID: 6653198
[No Abstract] [Full Text] [Related]
3. Clinical significance of cancer antigen 125 (CA 125) in ovarian cancer.
Crombach G; Zippel HH; Würz H
Cancer Detect Prev; 1985; 8(1-2):135-9. PubMed ID: 3864535
[TBL] [Abstract][Full Text] [Related]
4. Detection of malignant ovarian neoplasms: a review of the literature. III. Immunological detection and ovarian cancer-associated antigens.
Smith LH; Oi RH
Obstet Gynecol Surv; 1984 Jun; 39(6):346-60. PubMed ID: 6203071
[TBL] [Abstract][Full Text] [Related]
5. [Serum levels of the CA-125 antigen in the diagnosis of ovarian neoplasms].
Sopracordevole F; Finco B; Scarabelli C; Campagnutta E; Alimena C; Perin A
Minerva Ginecol; 1985 Oct; 37(10):589-96. PubMed ID: 3866146
[No Abstract] [Full Text] [Related]
6. [Studies on the serum levels of a carbohydrate antigen 19-9 (CA 19-9) in patients with ovarian cancer].
Miyoshi T; Nishimura H; Ookura N; Morisaki H; Kobayashi H; Tasaki T; Ushijima H; Yakushiji M
Igaku Kenkyu; 1984 Dec; 54(8):796-800. PubMed ID: 6599577
[No Abstract] [Full Text] [Related]
7. [Clinical evaluation of a cancer antigen CA125 associated with ovarian cancer. (III) Serum CA125 levels in patients with ovarian cancer and other gynecological tumors].
Suzuki M; Sekiguchi I; Tamada T; Sakurabayashi I; Kawai T
Rinsho Byori; 1985 Feb; 33(2):173-7. PubMed ID: 3858562
[No Abstract] [Full Text] [Related]
8. [Ovarian carcinoma-associated antigen isolated from peritoneal effusions in clinical diagnosis].
Qian HN
Zhonghua Fu Chan Ke Za Zhi; 1983 Oct; 18(4):242-6. PubMed ID: 6426896
[No Abstract] [Full Text] [Related]
9. Ovarian cancer: immunologic diagnosis and therapy.
Barber HR; Dorsett B
Contrib Gynecol Obstet; 1985; 14():176-84. PubMed ID: 3905251
[No Abstract] [Full Text] [Related]
10. Predictive value of CA 125 for ovarian carcinoma in patients presenting with pelvic masses.
Patsner B; Mann WJ; Chalas E
Obstet Gynecol; 1988 Jun; 71(6 Pt 1):949-50. PubMed ID: 3163416
[No Abstract] [Full Text] [Related]
11. Ovarian tumor antigens.
Benson MD; Lurain JR; Newton M
J Reprod Med; 1983 Jan; 28(1):17-23. PubMed ID: 6187917
[TBL] [Abstract][Full Text] [Related]
12. [Serum CA125, CA19-9 and TPA in the diagnostic approach to neoplastic pathology of the ovary].
Gadducci A; Bartolini T; Ferdeghini M; Facchini V; Bianchi R; Fioretti P
Minerva Ginecol; 1987 Sep; 39(9):601-6. PubMed ID: 3479708
[No Abstract] [Full Text] [Related]
13. High serum SCC antigen levels in two patients with ovarian cancer.
Yamada T; Ikeda A; Okamoto Y; Okamoto Y; Kanda T; Ueki M
Acta Obstet Gynecol Scand; 1997 Mar; 76(3):283-5. PubMed ID: 9093148
[No Abstract] [Full Text] [Related]
14. [Immunodiagnostic studies in ovarian cancer using the leukocyte adherence inhibition test (LAI test). 1. Detection of cellular sensitization of peripheral blood lymphocytes using the LAI test].
Ludwig HJ; Storch H
Zentralbl Gynakol; 1986; 108(10):593-606. PubMed ID: 3526755
[TBL] [Abstract][Full Text] [Related]
15. Initial immunochemical characterization of MX35 ovarian cancer antigen.
Welshinger M; Yin BW; Lloyd KO
Gynecol Oncol; 1997 Nov; 67(2):188-92. PubMed ID: 9367706
[TBL] [Abstract][Full Text] [Related]
16. [Serum levels of CA 125, CA 19-9, TPA, CEA and CA 50: useful evaluation parameters in the diagnosis of ovarian cancer].
Gadducci A; Ferdeghini M; Bartolini T; Facchini V; Bianchi R; Fioretti P
Ann Ostet Ginecol Med Perinat; 1986; 107(4):193-9. PubMed ID: 3467641
[No Abstract] [Full Text] [Related]
17. [Possibilities and limitations of the clinical use of specific monoclonal antibodies for epithelial ovarian carcinomas: CA125K].
Pozzi V; D'Onofrio T; Cappa F; Mascaretti G; Meggiorini ML; Nusiner MP; Danese M
Minerva Ginecol; 1985 May; 37(5):253-7. PubMed ID: 3861960
[No Abstract] [Full Text] [Related]
18. Tumour markers in ovarian cancer.
van Nagell JR
Clin Obstet Gynaecol; 1983 Aug; 10(2):197-212. PubMed ID: 6193919
[No Abstract] [Full Text] [Related]
19. [Clinical evaluation of a cancer antigen CA 125 associated with ovarian cancer. (IV) Serum CA 125 levels through normal menstrual cycle and in benign diseases].
Suzuki M; Sekiguchi I; Ohwada M; Tamada T; Sakurabayashi I; Kawai T
Rinsho Byori; 1985 Mar; 33(3):285-8. PubMed ID: 3859676
[No Abstract] [Full Text] [Related]
20. [Immunochemical study of antigens in the ascitic fluid of patients with ovarian cancer].
Sergeeva NS; Vasil'ev MIu; Avdeev GI
Eksp Onkol; 1986; 8(4):37-40. PubMed ID: 3757883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
